866-997-4948(US-Canada Toll Free)

Global Montelukast Drug Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Nov 2018

Category :

Pharmaceutical

No. of Pages : 122 Pages

Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
In 2017, the global Montelukast Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Montelukast Drug market based on company, product type, application and key regions.

This report studies the global market size of Montelukast Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Montelukast Drug in these regions.
This research report categorizes the global Montelukast Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Montelukast Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Montelukast Drug include
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical

Market Size Split by Type
Tablet
Chewable tablet
Oral Granules
Market Size Split by Application
Hospital
Drug store
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Montelukast Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Montelukast Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Montelukast Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Montelukast Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Montelukast Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Montelukast Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Montelukast Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Montelukast Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Montelukast Drug Market Size Growth Rate by Type
1.4.2 Tablet
1.4.3 Chewable tablet
1.4.4 Oral Granules
1.5 Market by Application
1.5.1 Global Montelukast Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drug store
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Montelukast Drug Market Size
2.1.1 Global Montelukast Drug Revenue 2016-2025
2.1.2 Global Montelukast Drug Sales 2016-2025
2.2 Montelukast Drug Growth Rate by Regions
2.2.1 Global Montelukast Drug Sales by Regions
2.2.2 Global Montelukast Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Montelukast Drug Sales by Manufacturers
3.1.1 Montelukast Drug Sales by Manufacturers
3.1.2 Montelukast Drug Sales Market Share by Manufacturers
3.1.3 Global Montelukast Drug Market Concentration Ratio (CR5 and HHI)
3.2 Montelukast Drug Revenue by Manufacturers
3.2.1 Montelukast Drug Revenue by Manufacturers (2016-2018)
3.2.2 Montelukast Drug Revenue Share by Manufacturers (2016-2018)
3.3 Montelukast Drug Price by Manufacturers
3.4 Montelukast Drug Manufacturing Base Distribution, Product Types
3.4.1 Montelukast Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Montelukast Drug Product Category
3.4.3 Date of International Manufacturers Enter into Montelukast Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Montelukast Drug Sales by Type
4.2 Global Montelukast Drug Revenue by Type
4.3 Montelukast Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Montelukast Drug Breakdown Data by Application

6 North America
6.1 North America Montelukast Drug by Countries
6.1.1 North America Montelukast Drug Sales by Countries
6.1.2 North America Montelukast Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Montelukast Drug by Type
6.3 North America Montelukast Drug by Application
6.4 North America Montelukast Drug by Company

7 Europe
7.1 Europe Montelukast Drug by Countries
7.1.1 Europe Montelukast Drug Sales by Countries
7.1.2 Europe Montelukast Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Montelukast Drug by Type
7.3 Europe Montelukast Drug by Application
7.4 Europe Montelukast Drug by Company

8 Asia Pacific
8.1 Asia Pacific Montelukast Drug by Countries
8.1.1 Asia Pacific Montelukast Drug Sales by Countries
8.1.2 Asia Pacific Montelukast Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Montelukast Drug by Type
8.3 Asia Pacific Montelukast Drug by Application
8.4 Asia Pacific Montelukast Drug by Company

9 Central & South America
9.1 Central & South America Montelukast Drug by Countries
9.1.1 Central & South America Montelukast Drug Sales by Countries
9.1.2 Central & South America Montelukast Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Montelukast Drug by Type
9.3 Central & South America Montelukast Drug by Application
9.4 Central & South America Montelukast Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Montelukast Drug by Countries
10.1.1 Middle East and Africa Montelukast Drug Sales by Countries
10.1.2 Middle East and Africa Montelukast Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Montelukast Drug by Type
10.3 Middle East and Africa Montelukast Drug by Application
10.4 Middle East and Africa Montelukast Drug by Company

11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.1.4 Montelukast Drug Product Description
11.1.5 Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.2.4 Montelukast Drug Product Description
11.2.5 Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.3.4 Montelukast Drug Product Description
11.3.5 Recent Development
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.4.4 Montelukast Drug Product Description
11.4.5 Recent Development
11.5 Hikma Group
11.5.1 Hikma Group Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.5.4 Montelukast Drug Product Description
11.5.5 Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.6.4 Montelukast Drug Product Description
11.6.5 Recent Development
11.7 Torrent Pharmaceuticals
11.7.1 Torrent Pharmaceuticals Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.7.4 Montelukast Drug Product Description
11.7.5 Recent Development
11.8 Lannett Company
11.8.1 Lannett Company Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.8.4 Montelukast Drug Product Description
11.8.5 Recent Development
11.9 Apotex
11.9.1 Apotex Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.9.4 Montelukast Drug Product Description
11.9.5 Recent Development
11.10 Dr. Reddys Laboratories
11.10.1 Dr. Reddys Laboratories Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Montelukast Drug
11.10.4 Montelukast Drug Product Description
11.10.5 Recent Development
11.11 Aurobindo Pharma
11.12 Accord Healthcare
11.13 Hetero
11.14 Unimark
11.15 Ajanta Pharma
11.16 MACLEODS
11.17 Jubilant Pharma
11.18 Unichem Laboratories
11.19 Amneal Pharmaceuticals
11.20 Shanghai Anbison Lab
11.21 Perrigo
11.22 Cipla
11.23 CSPC Ouyi Pharmaceutical

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Montelukast Drug Raw Material
13.1.2 Montelukast Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Montelukast Drug
Figure Global Montelukast Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Montelukast Drug Production Market Share by Types (Product Category) in 2017
Figure Tablet Product Picture
Table Major Manufacturers of Tablet
Figure Chewable tablet Product Picture
Table Major Manufacturers of Chewable tablet
Figure Oral Granules Product Picture
Table Major Manufacturers of Oral Granules
Table Global Montelukast Drug Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital
Figure Drug store
Figure Others
Figure Montelukast Drug Report Years Considered
Figure Global Montelukast Drug Market Size 2016-2025 (Million US$)
Figure Global Montelukast Drug Sales 2016-2025 (K Units)
Table Global Montelukast Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Montelukast Drug Sales by Regions 2016-2025 (K Units)
Table Global Montelukast Drug Sales Market Share by Regions 2016-2025
Figure Global Montelukast Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Montelukast Drug Sales Market Share by Regions
Table Global Montelukast Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Montelukast Drug Revenue Market Share by Regions 2016-2025
Figure Global Montelukast Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Montelukast Drug Revenue Market Share by Regions
Table Global Montelukast Drug Sales by Manufacturers (2016-2018) (K Units)
Table Global Montelukast Drug Sales Share by Manufacturers (2016-2018)
Figure Global Montelukast Drug Sales Share by Manufacturers in 2017
Table Montelukast Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Montelukast Drug Revenue Share by Manufacturers (2016-2018)
Figure Montelukast Drug Value Share by Manufacturers in 2017
Table Global Montelukast Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Montelukast Drug Price (2016-2018) (USD/Unit)
Table Montelukast Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Montelukast Drug Product Category
Table Date of International Manufacturers Enter into Montelukast Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Montelukast Drug Sales by Type (2016-2025) (K Units)
Table Global Montelukast Drug Sales Share by Type (2016-2025)
Figure Global Montelukast Drug Sales Market Share by Type (2016-2025)
Figure Global Montelukast Drug Sales Market Share by Type in 2017
Table Global Montelukast Drug Revenue by Type (2016-2025) (Million US$)
Table Global Montelukast Drug Revenue Share by Type (2016-2025)
Figure Global Montelukast Drug Revenue Market Share by Type (2016-2025)
Figure Global Montelukast Drug Revenue Market Share by Type in 2017
Table Montelukast Drug Price by Type 2013-2018 (USD/Unit)
Table Global Montelukast Drug Sales by Application (2016-2025) (K Units)
Table Global Montelukast Drug Sales Share by Application (2016-2025)
Figure Global Sales Montelukast Drug Market Share by Application (2016-2025)
Figure Global Sales Montelukast Drug Market Share by Application (2016-2025)
Figure North America Montelukast Drug Sales Growth Rate 2016-2025 (K Units)
Figure North America Montelukast Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Montelukast Drug Sales by Countries (2016-2025) (K Units)
Table North America Montelukast Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Montelukast Drug Sales Market Share by Countries
Table North America Montelukast Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Montelukast Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Montelukast Drug Revenue Market Share by Countries
Figure United States Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure United States Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Canada Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Montelukast Drug Sales by Type (2016-2025) (K Units)
Table North America Montelukast Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Montelukast Drug Market Share by Type
Table North America Montelukast Drug Sales by Application (2016-2025) (K Units)
Table North America Montelukast Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Montelukast Drug Market Share by Application
Table North America Montelukast Drug Sales by Company (2016-2018) (K Units)
Table North America Montelukast Drug Sales Market Share by Company (2016-2018)
Figure North America Montelukast Drug Sales Market Share by Company in 2017
Figure Europe Montelukast Drug Sales Growth Rate 2016-2025 (K Units)
Figure Europe Montelukast Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Montelukast Drug Sales by Countries (2016-2025) (K Units)
Table Europe Montelukast Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Montelukast Drug Sales Market Share by Countries
Table Europe Montelukast Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Montelukast Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Montelukast Drug Revenue Market Share by Countries
Figure Germany Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Germany Montelukast Drug Revenue Growth Rate (2016-2025) (K Units)
Figure France Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure France Montelukast Drug Revenue Growth Rate (2016-2025) (K Units)
Figure UK Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure UK Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Italy Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Russia Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Montelukast Drug Sales by Type (2016-2025) (K Units)
Table Europe Montelukast Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Montelukast Drug Market Share by Type
Table Europe Montelukast Drug Sales by Application (2016-2025) (K Units)
Table Europe Montelukast Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Montelukast Drug Market Share by Application
Table Europe Montelukast Drug Sales by Company (2016-2018) (K Units)
Table Europe Montelukast Drug Sales Market Share by Company (2016-2018)
Figure Europe Montelukast Drug Sales Market Share by Company in 2017
Figure Asia Pacific Montelukast Drug Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Montelukast Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Montelukast Drug Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Montelukast Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Montelukast Drug Sales Market Share by Countries
Table Asia Pacific Montelukast Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Montelukast Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Montelukast Drug Revenue Market Share by Countries
Figure China Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure China Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Japan Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Korea Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure India Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Australia Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Montelukast Drug Sales by Type (2016-2025) (K Units)
Table Asia Pacific Montelukast Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Montelukast Drug Market Share by Type
Table Asia Pacific Montelukast Drug Sales by Application (2016-2025) (K Units)
Table Asia Pacific Montelukast Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Montelukast Drug Market Share by Application
Table Asia Pacific Montelukast Drug Sales by Company (2016-2018) (K Units)
Table Asia Pacific Montelukast Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Montelukast Drug Sales Market Share by Company in 2017
Figure Central & South America Montelukast Drug Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Montelukast Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Montelukast Drug Sales by Countries (2016-2025) (K Units)
Table Central & South America Montelukast Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Montelukast Drug Sales Market Share by Countries
Table Central & South America Montelukast Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Montelukast Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Montelukast Drug Revenue Market Share by Countries
Figure Brazil Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Montelukast Drug Sales by Type (2016-2025) (K Units)
Table Central & South America Montelukast Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Montelukast Drug Market Share by Type
Table Central & South America Montelukast Drug Sales by Application (2016-2025) (K Units)
Table Central & South America Montelukast Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Montelukast Drug Market Share by Application
Table Central & South America Montelukast Drug Sales by Company (2016-2018) (K Units)
Table Central & South America Montelukast Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Montelukast Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Montelukast Drug Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Montelukast Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Montelukast Drug Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Montelukast Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Montelukast Drug Sales Market Share by Countries
Table Middle East and Africa Montelukast Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Montelukast Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Montelukast Drug Revenue Market Share by Countries
Figure GCC Countries Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Montelukast Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Montelukast Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Montelukast Drug Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Montelukast Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Montelukast Drug Market Share by Type
Table Middle East and Africa Montelukast Drug Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Montelukast Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Montelukast Drug Market Share by Application
Table Middle East and Africa Montelukast Drug Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Montelukast Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Montelukast Drug Sales Market Share by Company in 2017
Table Merck & Co. Company Details
Table Merck & Co. Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck & Co. Recent Development
Table Teva Company Details
Table Teva Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Recent Development
Table Mylan Company Details
Table Mylan Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mylan Recent Development
Table Glenmark Pharmaceuticals Company Details
Table Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Glenmark Pharmaceuticals Recent Development
Table Hikma Group Company Details
Table Hikma Group Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Hikma Group Recent Development
Table Sandoz Company Details
Table Sandoz Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sandoz Recent Development
Table Torrent Pharmaceuticals Company Details
Table Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Torrent Pharmaceuticals Recent Development
Table Lannett Company Company Details
Table Lannett Company Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Lannett Company Recent Development
Table Apotex Company Details
Table Apotex Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Apotex Recent Development
Table Dr. Reddys Laboratories Company Details
Table Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Dr. Reddys Laboratories Recent Development
Table Aurobindo Pharma Company Details
Table Accord Healthcare Company Details
Table Hetero Company Details
Table Unimark Company Details
Table Ajanta Pharma Company Details
Table MACLEODS Company Details
Table Jubilant Pharma Company Details
Table Unichem Laboratories Company Details
Table Amneal Pharmaceuticals Company Details
Table Shanghai Anbison Lab Company Details
Table Perrigo Company Details
Table Cipla Company Details
Table CSPC Ouyi Pharmaceutical Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Montelukast Drug Value Chain
Table Typical Suppliers of Key Montelukast Drug Raw Material
Table Montelukast Drug Customers List
Table Montelukast Drug Sales Channels
Table Montelukast Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *